BioNexus Gene Lab (BGLC) Competitors $4.90 +0.02 (+0.41%) Closing price 04:00 PM EasternExtended Trading$4.93 +0.03 (+0.61%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. CCM, MRAI, BRTX, MGRX, SSY, VSEE, ATIP, DHAC, ACON, and NIVFShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Concord Medical Services (CCM), Marpai (MRAI), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), VSee Health (VSEE), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), Aclarion (ACON), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Concord Medical Services Marpai Biorestorative Therapies Mangoceuticals SunLink Health Systems VSee Health ATI Physical Therapy Digital Health Acquisition Aclarion NewGenIvf Group Concord Medical Services (NYSE:CCM) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment. Does the media prefer CCM or BGLC? In the previous week, Concord Medical Services had 7 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 8 mentions for Concord Medical Services and 1 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.87 beat Concord Medical Services' score of -0.06 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Neutral BioNexus Gene Lab Very Positive Do institutionals and insiders believe in CCM or BGLC? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Comparatively, 0.7% of BioNexus Gene Lab shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is CCM or BGLC more profitable? Concord Medical Services has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -22.85%. Concord Medical Services' return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioNexus Gene Lab -22.85%-24.18%-20.14% Which has higher valuation & earnings, CCM or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$52.60M0.45-$42.23MN/AN/ABioNexus Gene Lab$9.27M0.95-$1.60MN/AN/A Which has more risk and volatility, CCM or BGLC? Concord Medical Services has a beta of -0.9, suggesting that its stock price is 190% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 5.08, suggesting that its stock price is 408% more volatile than the S&P 500. SummaryConcord Medical Services beats BioNexus Gene Lab on 6 of the 11 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.77M$7.30B$5.70B$9.51BDividend YieldN/A2.84%4.69%4.01%P/E RatioN/A15.7721.1920.14Price / Sales0.9542.18461.30104.37Price / CashN/A26.7436.2258.56Price / Book1.069.718.665.87Net Income-$1.60M$239.96M$3.25B$258.55M7 Day Performance-3.92%2.92%4.20%2.23%1 Month Performance87.02%6.14%10.82%12.76%1 Year Performance-2.99%17.27%34.70%19.36% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab1.2014 of 5 stars$4.90+0.4%N/A-4.1%$8.77M$9.27M0.0030Positive NewsCCMConcord Medical Services1.0849 of 5 stars$5.31+1.6%N/A-19.3%$23.03M$52.60M0.00970Gap DownMRAIMarpaiN/A$1.37+1.5%N/A+116.1%$22.65M$34.87M-0.52150News CoverageBRTXBiorestorative Therapies3.8083 of 5 stars$1.53-4.7%$18.00+1,080.3%-3.8%$11.44M$400K-1.047Positive NewsMGRXMangoceuticals0.9776 of 5 stars$1.47-3.3%N/A-98.1%$7.60M$511.08K-0.323SSYSunLink Health Systems2.5538 of 5 stars$1.00+3.2%N/A+55.2%$7.05M$31.09M7.151,376News CoverageDividend AnnouncementVSEEVSee Health1.0839 of 5 stars$1.32-4.3%$5.00+278.8%-56.1%$4.75MN/A0.00N/AGap DownATIPATI Physical TherapyN/A$1.03flatN/A-94.2%$4.54M$741.86M-0.065,600DHACDigital Health AcquisitionN/A$1.22+3.4%N/A-62.8%$4.40MN/A0.002,021ACONAclarion2.9896 of 5 stars$7.34+0.1%$11,758.50+160,097.5%-99.7%$4.27M$54.60K0.007Gap DownNIVFNewGenIvf GroupN/A$0.59-7.3%N/A-99.7%$2.54M$5.43M0.00N/APositive News Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives BRTX Alternatives MGRX Alternatives SSY Alternatives VSEE Alternatives ATIP Alternatives DHAC Alternatives ACON Alternatives NIVF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
